Brimonidine tartrate and timolol maleate side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Brimonidine tartrate and timolol maleate. Common side effects include eye disorder among females and ankylosing spondylitis among males.

The phase IV clinical study is created by eHealthMe based on 20 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 26, 2022

20 people who take Brimonidine Tartrate And Timolol Maleate and have side effects are studied.


What is Brimonidine Tartrate And Timolol Maleate?

Brimonidine tartrate and timolol maleate has active ingredients of brimonidine tartrate; timolol maleate. eHealthMe is studying from 20 Brimonidine tartrate and timolol maleate users for its effectiveness, alternative drugs and more.

Number of Brimonidine tartrate and timolol maleate reports submitted per year:

Brimonidine tartrate and timolol maleate side effects.

Brimonidine Tartrate And Timolol Maleate side effects by time on the drug*:

< 1 month:

  1. Bradycardia (abnormally slow heart action)

1 - 6 months:

n/a

6 - 12 months:

  1. Blood pressure increased

1 - 2 years:

  1. Corneal thinning

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. Eye disorder
  2. Retinopathy haemorrhagic (acute damage to the retina of the eye with bleeding)
  3. Blindness unilateral
  4. Cardiac failure congestive
  5. Death
  6. Ankylosing spondylitis (type of arthritis affecting the spine)
  7. Blepharitis (chronic inflammation of the eyelid)
  8. Blindness
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

Brimonidine Tartrate And Timolol Maleate side effects by gender *:

female:

  1. Eye disorder
  2. Retinopathy haemorrhagic (acute damage to the retina of the eye with bleeding)
  3. Cardiac failure congestive
  4. Death
  5. Blindness unilateral
  6. Blood pressure increased
  7. Bradycardia (abnormally slow heart action)

male:

  1. Ankylosing spondylitis (type of arthritis affecting the spine)
  2. Blepharitis (chronic inflammation of the eyelid)
  3. Blindness
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Corneal thinning

Brimonidine Tartrate And Timolol Maleate side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Blood pressure increased
  2. Bradycardia (abnormally slow heart action)

60+:

  1. Death
  2. Retinopathy haemorrhagic (acute damage to the retina of the eye with bleeding)
  3. Blepharitis (chronic inflammation of the eyelid)
  4. Blindness
  5. Blindness unilateral
  6. Corneal thinning

* Approximation only. Some reports may have incomplete information.

Do you take Brimonidine tartrate and timolol maleate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on brimonidine tartrate; timolol maleate (the active ingredients of Brimonidine tartrate and timolol maleate) and Brimonidine tartrate and timolol maleate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Brimonidine tartrate and timolol maleate:

All Brimonidine tartrate and timolol maleate side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: